Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of…
CertaraJanuary 7, 2026
Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions
Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions
Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…
CertaraDecember 29, 2025
Strategic Project Management for Accelerated Drug Development
Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…
CertaraDecember 23, 2025
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection
This study synthesizes data from a large body of clinical trials to evaluate rates of…
CertaraDecember 18, 2025
Accelerated ADC Approval Through Expert Modeling and Data Rescue
See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…
CertaraDecember 15, 2025
Merck Advances Pediatric Oncology with Innovative ADC Modeling
Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…
CertaraDecember 12, 2025
New Approach Methodologies (NAMs): By the numbers
We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…
CertaraDecember 10, 2025
Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings
Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.
CertaraDecember 3, 2025
